| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.800 | None | 0.966 | 0 | 0 | 2002 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.967 | 5 | 0 | 1993 | 2020 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.400 | None | 0.967 | 1 | 0 | 2002 | 2019 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.400 | None | 0.968 | 1 | 0 | 2009 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 1.000 | None | 0.969 | 0 | 0 | 1994 | 2020 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
disease | 0.400 | None | 0.972 | 4 | 0 | 1977 | 2020 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.400 | None | 0.972 | 2 | 0 | 1997 | 2020 | ||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
disease | 0.400 | None | 0.972 | 1 | 0 | 1997 | 2020 | ||||||||
|
heat shock protein family A (Hsp70) member 5 | 0.434 | 0.885 | 0.77 |
|
disease | 0.400 | None | 0.974 | 2 | 0 | 2001 | 2020 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.600 | None | 0.977 | 4 | 0 | 1998 | 2019 | ||||||||
|
E2F transcription factor 1 | 0.441 | 0.846 | 0.99 |
|
disease | 0.400 | None | 0.977 | 3 | 0 | 2001 | 2019 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.400 | None | 0.978 | 3 | 0 | 2001 | 2019 | |||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.978 | 1 | 0 | 1990 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.979 | 1 | 0 | 1990 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.980 | 2 | 0 | 1995 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.500 | None | 0.981 | 1 | 0 | 2004 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.800 | strong | 0.982 | 5 | 0 | 1998 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.983 | 1 | 0 | 2007 | 2020 | ||||||||
|
glypican 3 | 0.466 | 0.808 | 1.00 |
|
disease | 0.600 | None | 0.984 | 2 | 0 | 1997 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.700 | None | 0.984 | 2 | 0 | 1996 | 2019 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.400 | None | 0.985 | 1 | 0 | 1985 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.985 | 1 | 0 | 1985 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.400 | None | 0.986 | 1 | 0 | 1990 | 2020 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.700 | None | 0.987 | 2 | 0 | 1989 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.989 | 4 | 0 | 1988 | 2020 |